Cargando…

GANT61 suppresses cell survival, invasion and epithelial-mesenchymal transition through inactivating AKT/mTOR and JAK/STAT3 pathways in anaplastic thyroid carcinoma

Glioma-associated oncogene (Gli) antagonist-61 (GANT61) not only suppresses the malignant behavior of several cancers but also presents synergistic effects with other anticancer agents on suppressing the progression of cancers, while relevant information is rare in anaplastic thyroid carcinoma (ATC)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Haoji, Wang, Weige, Li, Qinyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067515/ https://www.ncbi.nlm.nih.gov/pubmed/35491899 http://dx.doi.org/10.1080/15384047.2022.2051158

Ejemplares similares

GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis
por: Srivastava, Ritesh K., et al.
Publicado: (2014)

Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition
por: Miyazaki, Yumi, et al.
Publicado: (2016)

Apatinib-induced protective autophagy and apoptosis through the AKT–mTOR pathway in anaplastic thyroid cancer
por: Feng, Haoran, et al.
Publicado: (2018)

Downregulation of AKT/mTOR signaling pathway for Salmonella-mediated autophagy in human anaplastic thyroid cancer
por: Wu, Li-Hsien, et al.
Publicado: (2022)

The Effect of Metformin and GANT61 Combinations on the Radiosensitivity of Prostate Cancer Cells
por: Gonnissen, Annelies, et al.
Publicado: (2017)

Linalool Impress Colorectal Cancer Deterioration by Mediating AKT/mTOR and JAK2/STAT3 Signaling Pathways
por: Hou, Min, et al.
Publicado: (2022)

GANT61, a GLI inhibitor, sensitizes glioma cells to the temozolomide treatment
por: Li, Jianlong, et al.
Publicado: (2016)

Retracted: Linalool Impress Colorectal Cancer Deterioration by Mediating AKT/mTOR and JAK2/STAT3 Signaling Pathways
por: International, BioMed Research
Publicado: (2023)

The protective autophagy activated by GANT-61 in MYCN amplified neuroblastoma cells is mediated by PERK
por: Wang, Jing, et al.
Publicado: (2018)

Chemical, computational and functional insights into the chemical stability of the Hedgehog pathway inhibitor GANT61
por: Calcaterra, Andrea, et al.
Publicado: (2018)

GANT61/BI-847325 combination: a new hope in lung cancer treatment
por: El-Kishky, Abdel Halim M., et al.
Publicado: (2022)

Rapamycin-Induced Apoptosis in HGF-Stimulated Lens Epithelial Cells by AKT/mTOR, ERK and JAK2/STAT3 Pathways
por: Tian, Fang, et al.
Publicado: (2014)

Simvastatin Inhibits Renal Cancer Cell Growth and Metastasis via AKT/mTOR, ERK and JAK2/STAT3 Pathway
por: Fang, Zhiqing, et al.
Publicado: (2013)

Thyroid Hormone Receptor Beta Inhibits PI3K-Akt-mTOR Signaling Axis in Anaplastic Thyroid Cancer via Genomic Mechanisms
por: Davidson, Cole D, et al.
Publicado: (2021)

Inhibition of autophagy potentiates the efficacy of Gli inhibitor GANT-61 in MYCN-amplified neuroblastoma cells
por: Wang, Jing, et al.
Publicado: (2014)

Mitochondria-derived reactive oxygen species drive GANT61-induced mesothelioma cell apoptosis
por: Lim, Chuan Bian, et al.
Publicado: (2015)

Targeting GLI by GANT61 involves mechanisms dependent on inhibition of both transcription and DNA licensing
por: Zhang, Ruowen, et al.
Publicado: (2016)

Unraveling the therapeutic potential of GANT61/Dactolisib combination as a novel prostate cancer modality
por: Youssef, Mohamed, et al.
Publicado: (2022)

Resveratrol provides neuroprotection by regulating the JAK2/STAT3/PI3K/AKT/mTOR pathway after stroke in rats
por: Hou, Yongying, et al.
Publicado: (2018)

Combined Effects of Baicalein and Docetaxel on Apoptosis in 8505c Anaplastic Thyroid Cancer Cells via Downregulation of the ERK and Akt/mTOR Pathways
por: Park, Chan Ho, et al.
Publicado: (2018)

GLI1 inhibitor GANT61 exhibits antitumor efficacy in T-cell lymphoma cells through down-regulation of p-STAT3 and SOCS3
por: Geng, Lingyun, et al.
Publicado: (2016)

Mode and specificity of binding of the small molecule GANT61 to GLI determines inhibition of GLI-DNA binding
por: Agyeman, Akwasi, et al.
Publicado: (2014)

The hedgehog inhibitor GANT61 sensitizes prostate cancer cells to ionizing radiation both in vitro and in vivo
por: Gonnissen, Annelies, et al.
Publicado: (2016)

Miss Zilphia Gant
por: Faulkner, William, 1897-1962
Publicado: (1971)

Miss Zilphia Gant
por: Faulkner, William, 1897-1962

Gant on Bladder Diseases
Publicado: (1877)

Thymoquinone Inhibits JAK/STAT and PI3K/Akt/ mTOR Signaling Pathways in MV4-11 and K562 Myeloid Leukemia Cells
por: Al-Rawashde, Futoon Abedrabbu, et al.
Publicado: (2022)

GANT61 and Valproic Acid Synergistically Inhibited Multiple Myeloma Cell Proliferation via Hedgehog Signaling Pathway
por: Zhang, Zhihua, et al.
Publicado: (2020)

Glycolysis is suppressed by DCZ0801-induced inactivation of the Akt/mTOR pathway in Multiple Myeloma
por: Feng, Qilin, et al.
Publicado: (2020)

The Paradox of Akt-mTOR Interactions
por: Vadlakonda, Lakshmipathi, et al.
Publicado: (2013)

Zhenzhu Xiaoji Decoction Induces Autophagy and Apoptosis Cell Death in Liver Cancer Cells through AKT/mTOR and JAK2/STAT3 Signaling Pathway
por: Sun, Yang, et al.
Publicado: (2022)

Fray Pedro de Gante
por: Chávez, Ezequiel A., 1868-1946
Publicado: (1962)

Gant's Science and Practice of Surgery
Publicado: (1872)

Regulation of Osteoclast Growth and Fusion by mTOR/raptor and mTOR/rictor/Akt
por: Tiedemann, Kerstin, et al.
Publicado: (2017)

Clinical potential of novel therapeutic targets in breast cancer: CDK4/6, Src, JAK/STAT, PARP, HDAC, and PI3K/AKT/mTOR pathways
por: Hosford, Sarah R, et al.
Publicado: (2014)

Downregulation of BZW2 inhibits osteosarcoma cell growth by inactivating the Akt/mTOR signaling pathway
por: Cheng, Dong-Dong, et al.
Publicado: (2017)

Inhibitory effects of petasin on human colon carcinoma cells mediated by inactivation of Akt/mTOR pathway
por: Lyu, Xi, et al.
Publicado: (2019)

CircNR3C1 Alleviates Gastric Cancer Development by Inactivating AKT/mTOR
por: Wang, Luben, et al.
Publicado: (2022)

JAK2-STAT5 signaling: A novel mechanism of resistance to targeted PI3K/mTOR inhibition
por: Yeh, Jennifer E, et al.
Publicado: (2013)

Anti‐cancer stem cell activity of a hedgehog inhibitor GANT61 in estrogen receptor‐positive breast cancer cells
por: Kurebayashi, Junichi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nqbtlttloi6l0aatv9ddmd789p